GLP-1 drugs may reduce alcohol cravings and change how Americans order drinks, creating new risks and opportunities for spirits brands, bars and restaurants.

GLP-1 drugs may reduce alcohol cravings and change how Americans order drinks, creating new risks and opportunities for spirits brands, bars and restaurants.

GLP-1 receptor agonists are among the active ingredients in so-called weight-loss injections. Originally developed to treat type 2 diabetes, they are now also used to treat severe…